Full-Time

Senior/Principal Scientist

Machine Learning

Posted on 7/3/2024

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Senior

Cambridge, MA, USA

Category
Applied Machine Learning
Deep Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python
Tensorflow
Pytorch
Requirements
  • PhD in a computational field (e.g., machine learning, computer science, applied math, neuroscience, computational biology, physics, etc.)
  • Strong publication record in deep learning research, particularly with large language models
  • Prior industry experience (3+ years)
  • Fluency in Python and standard ML tools and packages and libraries (e.g. PyTorch, TensorFlow, Jax, sklearn)
  • Motivated and team oriented, with an ability to thrive in a multidisciplinary environment
  • Excellent communication and presentation skills
  • Must be able to think independently and work collaboratively
  • Management and leadership experience preferred
Responsibilities
  • Lead the development of advanced ML tools that capture and recapitulate psychological phenomena.
  • Design & run key experiments of LLM-based multi-agent systems.
  • Leverage real-world data to fine-tune and validate agent behavior.
  • Design an optimized data pipeline to facilitate development, scalability, and integration with a user-facing product.
  • Experiment with techniques to augment the performance of the platform.
  • Collaborate closely with other members of the team to enhance platform KPIs.
  • Collaborate closely with software developers to integrate platform with user-facing product.
  • Communicate findings to a multi-disciplinary audience.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.
  • Strategic partnerships with Pfizer enhance drug discovery and development capabilities.
  • Inari Agriculture's $2.17 billion valuation highlights successful investment strategy.

What critics are saying

  • Over-reliance on strategic partnerships with large pharmaceutical companies poses potential risks.
  • High-profile executive appointments may lead to cultural clashes within teams.
  • Focus on first-in-category ventures may result in higher R&D costs and longer profitability timelines.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • Combines innovative capacity, entrepreneurial leadership, and capital management in one enterprise.
  • Uses evolutionary methodology to navigate from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.

Bloomberg
Jan 7th, 2025
Ag Tech Startup Inari Gets $2.17 Billion Valuation in Latest Funding Round

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a roughly 32% jump from a prior mark of $1.65 billion set last January.

Contract Pharma
Nov 21st, 2024
Flagship Pioneering Enters Agreements Under Strategic Pfizer Pact

Flagship Pioneering, a bioplatform company, entered agreements with Ampersand Biomedicines and Montai Therapeutics to identify targeted molecules that could be further developed as treatments for obesity and non-small cell lung cancer (NSCLC).

INACTIVE